Angiotensin II activates Src and ERKs independently of heterotrimeric G protein coupling via the AT1 receptor carboxyl terminus, but these ERKs fail to translocate to the nucleus.
The study demonstrates that Angiotensin II can activate Src and ERKs independently of heterotrimeric G protein coupling, but this pathway fails to induce nuclear translocation of ERKs, highlighting distinct roles for G protein-dependent and -independent signaling.
Angiotensin II (Ang II) type 1 receptors (AT1Rs) activate tyrosine kinases, including Src. Whether or not tyrosine kinase activation by AT1R occurs independently of heterotrimeric G protein coupling and, if so, the cellular function of such a mechanism are unknown. To address these questions, we used an AT1aR intracellular second loop mutant, which lacks heterotrimeric G protein coupling (AT1a-i2m). Surprisingly, Ang II-induced Src activation was preserved in AT1a-i2m, which was not attenuated by inhibiting protein kinase C and Ca(2+) or by inhibiting Galpha(i) or Galpha(q) in CHO-K1 cells. By contrast, Ang II-induced Src activation was abolished in a C-terminally truncated AT1a-(1--309), where Ang II-induced inositol phosphate response was preserved. Ang II activates ERKs via a Src-Ras-dependent mechanism in AT1a-i2m. ERKs activated by AT1a-i2m phosphorylate their cytoplasmic targets, including p90(RSK), but fail to translocate into the nucleus or to cause cell proliferation. Ang II-induced nuclear translocation of ERKs by wild type AT1aR was inhibited by overexpression of nuclear exportin Crm-1, while that by AT1a-i2m was restored by leptomycin B, an inhibitor of Crm-1. In summary, while Src and ERKs are activated by Ang II even without heterotrimeric G protein coupling, the carboxyl terminus of the AT1 receptor is required for activation of Src. Interestingly, ERKs activated by heterotrimeric G protein-independent mechanisms fail to phosphorylate nuclear targets due to lack of inhibition of Crm-1-induced nuclear export of ERKs. These results suggest that heterotrimeric G protein-dependent and -independent signaling mechanisms play distinct roles in Ang II-mediated cellular responses.
Seta et al. (Fri,) conducted a other in Angiotensin II receptor signaling. Angiotensin II and AT1aR mutants (AT1a-i2m, AT1a-(1-309)) vs. Wild type AT1aR was evaluated on Src and ERK activation and nuclear translocation. Angiotensin II activates Src and ERKs independently of heterotrimeric G protein coupling via the AT1 receptor carboxyl terminus, but these ERKs fail to translocate to the nucleus.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: